TGF-β, a prominent immunoregulatory cytokine secreted by both TAMs and tumour cells, suppresses NK cell activation by downregulating NKG2D and NKp30 (81), while concurrently promoting macrophage polarisation toward an immunosuppressive phenotype and reducing pro-inflammatory cytokine output (82). The gene discussed is NCR3; the disease is neoplasm.